Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Jun. 30, 2012
Dec. 31, 2011
ASSETS    
Cash and cash equivalents $ 5,000 $ 92,000
Inventories 92,000 12,000
Prepaid expenses 12,000 0
Total Current Assets 109,000 104,000
Patents, net 16,000 25,000
Total Other Assets 16,000 25,000
TOTAL ASSETS 125,000 129,000
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Accounts payable 813,000 806,000
Accrued interest 1,157,000 1,598,000
Accrued expenses 1,870,000 607,000
Line of credit 26,000 25,000
Warrant liability 514,000 158,000
Demand notes payable, net of discount of $14,000 and $54,000 249,000 266,000
Convertible debentures, net of discount of $0 and $0, current portion 1,183,000 775,000
Convertible debentures 747,000 995,000
Total Current Liabilities 6,559,000 5,230,000
Minority interest      
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C - 96,230 and 96,230 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively 1,000 1,000
Series H - 25,000 and 25,000 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively 0 0
Series I - 1,666,667 and 1,666,667 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively 2,000 2,000
Common stock - $0.001 par value; 600,000,000 shares authorized; 364,299,838 and 269,299,838 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively 364,000 269,000
Additional paid-in capital 80,017,000 78,422,000
Accumulated deficit (86,805,000) (83,795,000)
Minority interest (13,000) 0
Total Stockholders' Deficit (6,434,000) (5,101,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 125,000 $ 129,000